This inventor holds 2 USPTO granted patents. Top assignees: Astrazeneca Ab, Navidea Biopharmaceuticals, Inc.. Active years: 2012-2015.
Company Filing History:
Years Active: 2012-2015
Title: The Innovative Contributions of Peter Strom
Introduction
Peter Strom is a notable inventor based in Sodertalje, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for medical applications. With a total of 2 patents, his work focuses on addressing critical health issues, including Alzheimer's disease.
Latest Patents
Strom's latest patents revolve around heteroaryl substituted benzothiazoles. These inventions relate to novel derivatives and their therapeutic uses, particularly in imaging amyloid deposits in living patients. The structural formula of these compounds is crucial for their application in diagnosing Alzheimer's disease and measuring the efficacy of therapeutic agents. His work aims to facilitate antemortem diagnosis, which is vital for timely intervention in Alzheimer's treatment.
Career Highlights
Throughout his career, Peter Strom has worked with prominent companies in the pharmaceutical industry. Notable among these are AstraZeneca AB and Navidea Biopharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Strom has collaborated with several professionals in his field, including Ylva Gravenfors and Catrin Jonasson. These partnerships have enhanced his research and development efforts, leading to impactful inventions.
Conclusion
Peter Strom's innovative work in the pharmaceutical sector, particularly in the development of compounds for Alzheimer's diagnosis, showcases his commitment to advancing medical science. His contributions are significant in the ongoing fight against neurodegenerative diseases.